rs1553253989
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_013386.5(SLC25A24):c.650G>A(p.Arg217His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R217C) has been classified as Pathogenic.
Frequency
Consequence
NM_013386.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A24 | NM_013386.5 | c.650G>A | p.Arg217His | missense_variant | 5/10 | ENST00000565488.6 | NP_037518.3 | |
SLC25A24 | NM_213651.3 | c.593G>A | p.Arg198His | missense_variant | 5/10 | NP_998816.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A24 | ENST00000565488.6 | c.650G>A | p.Arg217His | missense_variant | 5/10 | 1 | NM_013386.5 | ENSP00000457733 | P1 | |
SLC25A24 | ENST00000370041.4 | c.593G>A | p.Arg198His | missense_variant | 5/10 | 1 | ENSP00000359058 | |||
SLC25A24 | ENST00000648874.1 | c.650G>A | p.Arg217His | missense_variant, NMD_transcript_variant | 5/11 | ENSP00000497117 | ||||
SLC25A24 | ENST00000264128.13 | c.*229G>A | 3_prime_UTR_variant, NMD_transcript_variant | 4/9 | 5 | ENSP00000264128 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpretted as Uncertain significance and reported on 08-17-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 06, 2024 | Published functional studies suggest that this variant results in mitochondrial dysfunction (PMID: 29100093, 29100094); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30329211, 30281880, 29100093, 29100094, 21216154, 19731360, 10594888, 31775791, 31231135, 36093452, Pannier2022[Abstract], 37449547, 36647814) - |
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Fontaine progeroid syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Oct 04, 2016 | The variant was identified as de novo in three independent cases with the syndrome and functional studies have shown a likely altered function of the protein. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 11, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at